US Federal House Bill HB421

US Federal 2023-2024 Regular Session

• Introduced: 1/20/23
• Refer: 1/20/23

Caption

Teleabortion Prevention Act of 2023 This bill restricts the use of telehealth for chemical abortions (also known as medication abortions). Specifically, it requires a provider who dispenses or prescribes medication for a chemical abortion to physically examine the patient, be physically present at the location of the chemical abortion, and schedule a follow-up visit for the patient. The bill provides an exception for a chemical abortion that is necessary to save the life of a mother whose life is endangered by a physical disorder, illness, injury, or condition. The bill establishes criminal penalties—a fine, a prison term of up to two years, or both—for a provider who does not comply with the requirements. A patient who undergoes a chemical abortion may not be prosecuted.

Impact

If enacted, HB421 would significantly impact the legal landscape surrounding abortion access in the United States by limiting the means through which chemical abortions can be conducted. The bill establishes criminal penalties for providers who do not comply, including fines of up to $1,000 and potential imprisonment for up to two years. The legislation is targeted at curbing the use of telehealth services for abortion care, reflecting an ongoing debate about the adequacy of virtual consultations for such medical procedures.

Summary

House Bill 421, also known as the Teleabortion Prevention Act of 2023, aims to regulate the provision of chemical abortions by imposing strict requirements on healthcare providers. Specifically, the bill mandates that any healthcare provider administering a chemical abortion must physically examine the patient, be present at the abortion site, and schedule a follow-up visit within 14 days of the procedure. These provisions are designed to ensure that patients receive adequate care and oversight during the process, with exceptions made for situations where a chemical abortion is necessary to save the life of the mother.

Contention

The bill has ignited a complex debate among legislators, healthcare professionals, and advocacy groups. Supporters argue that the requirement for a physical presence of healthcare providers will protect women’s health and ensure proper medical support during the abortion process. Conversely, opponents criticize the bill as an undue burden on reproductive rights, asserting that it could limit access to safe and necessary healthcare. The provisions may particularly affect individuals in rural or underserved areas, where access to healthcare providers is already challenging.